Intravenous Cereport (RMP-7) Modifies Topographic Uptake Profile of Carboplatin within Rat Glioma and Brain surrounding Tumor, Elevates Platinum Levels, and Enhances Survival
Authors:
- Raymond T. BartusRBRaymond T. Bartus
- Pamela SnodgrassPSPamela Snodgrass
- Joanne MarshJMJoanne Marsh
- Mary AgostinoMAMary Agostino
- Alexis PerkinsAPAlexis Perkins
- Dwaine F. EmerichDEDwaine F. Emerich
- 1 June 2000
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 293 (3) , 903-911
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Phase II Studies of RMP-7 and Carboplatin in the Treatment of Recurrent High Grade GliomaJournal of Neuro-Oncology, 1999
- Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomasBrain Research, 1998
- Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7Experimental Neurology, 1996
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7Immunopharmacology, 1996
- Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated systemImmunopharmacology, 1996
- Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7Brain Research, 1995
- Biochemical opening of the blood-brain barrierAdvanced Drug Delivery Reviews, 1995
- In Vitro Plasma Metabolism of RMP-7Pharmaceutical Research, 1994
- Leukotrienes increase blood‐brain barrier permeability following intraparenchymal injections in ratsAnnals of Neurology, 1985